Results 41 to 50 of about 39,492 (194)
Allergic Bronchopulmonary Aspergillosis/Mycosis: An Underdiagnosed Disease
Solange Oliveira Rodrigues Valle +2 more
openalex +1 more source
A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom [PDF]
Chalid Assaf +11 more
openalex +1 more source
ABSTRACT Since 2004, patients receiving imatinib with relapse in non‐marrow sites were given dasatinib to preserve control of leukemic marrow. Remissions in CNS and other organs began to be reported and are continuously observed to present. With resistance to one BCR::ABL1 tyrosine kinase inhibitor and sensitivity to a dual BCR::ABL1/SRC inhibitor ...
I. Cunningham +4 more
wiley +1 more source
ABSTRACT Objectives To determine the diagnostic value of disclosing monotypic T‐cell populations by expression analysis of the constant region 1 of T‐cell receptor β (TRBC1) by flow cytometry, for the detection of T‐cell neoplasms, in a routine hematopathology practice setting.
Nilofar Rajabian +4 more
wiley +1 more source
Elastolytic Granulomatous Dermatoses: Toward a Unified Clinicopathological Concept
International Journal of Dermatology, EarlyView.
Rose Kathrin Caroline Moritz +2 more
wiley +1 more source
Syringotropic Mycosis Fungoides
Brief description of a syringotropic mycosis fungoides.
Edmond Demoulins, Clémence Berthin
openaire +3 more sources
Mycosis Fungoides and Sezary Syndrome T1b TNM Finding v8 [PDF]
National Cancer Institute
openalex +1 more source
Beyond bacterial defences: the role of lysozyme in cancer
Lysozyme (LYZ) is a multi‐functional secreted factor that encompasses both antibacterial and immunomodulatory functions. Emerging evidence highlights its complex role in tumour progression by directly influencing tumour cells and modulating the immune microenvironment.
Lei Wang +4 more
wiley +1 more source
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions
ABSTRACT Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. The clinical presentation of AD is heterogeneous and is characterized by a relapsing and remitting course. Most patients suffer from mild AD while approximately 5% to 20% experience severe disease activity, which often requires systemic treatment ...
Marjolein S. de Bruin‐Weller +9 more
wiley +1 more source

